{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:29:03Z","timestamp":1793363343421,"version":"4.5.0"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Augie's Quest to Cure ALS"},{"name":"ALSONE"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Amyotrophic lateral sclerosis (ALS) has been linked to overactivity of the protein kinase RNA-like ER kinase (PERK) branch of the unfolded protein response (UPR) pathway, both in ALS patients and mouse models. However, attempts to pharmacologically modulate PERK for therapeutic benefit have yielded inconsistent and often conflicting results. This study sought to address these discrepancies by comprehensively evaluating three commonly used, CNS-penetrant, PERK modulators (GSK2606414, salubrinal, and Sephin1) in the same experimental models, with the goal of assessing the viability of targeting the PERK pathway as a therapeutic strategy for ALS. To achieve this goal, a tunicamycin-challenge assay was developed using wild-type mice to monitor changes in liver UPR gene expression in response to PERK pathway modulation. Subsequently, multiple dosing regimens of each PERK modulator were tested in standardized, well-powered, gender-matched, and litter-matched survival efficacy studies using the SOD1G93A mouse model of ALS. The alpha-2-adrenergic receptor agonist clonidine was also tested to elucidate the results obtained from the Sephin1, and of the previously reported guanabenz studies, by comparing the effects of presence or absence of \u03b1-2 agonism. The results revealed that targeting PERK may not be an ideal approach for ALS treatment. Inhibiting PERK with GSK2606414 or activating it with salubrinal did not confer therapeutic benefits. While Sephin1 showed some promising therapeutic effects, it appears that these outcomes were mediated through PERK-independent mechanisms. Clonidine also produced some favorable therapeutic effects, which were unexpected and not linked to the UPR. In conclusion, this study highlights the challenges of pharmacologically targeting PERK for therapeutic purposes in the SOD1G93A mouse model and suggests that exploring other targets within, and outside, the UPR may be more promising avenues for ALS treatment.<\/jats:p>","DOI":"10.1371\/journal.pone.0292190","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T18:42:11Z","timestamp":1708022531000},"page":"e0292190","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["PERK modulation, with GSK2606414, Sephin1 or salubrinal, failed to produce therapeutic benefits in the SOD1G93A mouse model of ALS"],"prefix":"10.1371","volume":"19","author":[{"given":"Fernando G.","family":"Vieira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie R.","family":"Tassinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0876-2460","authenticated-orcid":true,"given":"Theo","family":"Hatzipetros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,2,15]]},"reference":[{"key":"pone.0292190.ref001","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fnmol.2017.00123","article-title":"Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities?","volume":"10","author":"CP Webster","year":"2017","journal-title":"Front Mol Neurosci."},{"issue":"3","key":"pone.0292190.ref002","doi-asserted-by":"crossref","first-page":"a013169","DOI":"10.1101\/cshperspect.a013169","article-title":"Endoplasmic reticulum stress sensing in the unfolded protein response.","volume":"5","author":"BM Gardner","year":"2013","journal-title":"Cold Spring Harb Perspect Biol."},{"issue":"2","key":"pone.0292190.ref003","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrm3270","article-title":"The unfolded protein response: controlling cell fate decisions under ER stress and beyond","volume":"13","author":"C. Hetz","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"pone.0292190.ref004","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1101\/gad.12.7.982","article-title":"CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum","volume":"12","author":"H Zinszner","year":"1998","journal-title":"Genes Dev"},{"key":"pone.0292190.ref005","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fnmol.2017.00187","article-title":"The Endoplasmic Reticulum Unfolded Protein Response in Neurodegenerative Disorders and Its Potential Therapeutic Significance.","volume":"10","author":"P Remondelli","year":"2017","journal-title":"Front Mol Neurosci."},{"key":"pone.0292190.ref006","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fgene.2014.00076","article-title":"Physiological roles of regulated Ire1 dependent decay.","volume":"5","author":"DS Coelho","year":"2014","journal-title":"Front Genet."},{"issue":"2","key":"pone.0292190.ref007","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3109\/17482968.2011.641569","article-title":"Endoplasmic reticulum stress and the ER mitochondrial calcium cycle in amyotrophic lateral sclerosis.","volume":"13","author":"J Lautenschlaeger","year":"2012","journal-title":"Amyotrophic Lateral Scler"},{"issue":"4","key":"pone.0292190.ref008","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrn3689","article-title":"Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases.","volume":"15","author":"C Hetz","year":"2014","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"pone.0292190.ref009","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/NEN.0b013e3181d44992","article-title":"Endoplasmic reticulum stress in motor neurons of the spinal cord in sporadic amyotrophic lateral sclerosis","volume":"69","author":"S. Sasaki","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Pt 12","key":"pone.0292190.ref010","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1093\/brain\/awm190","article-title":"Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis","volume":"130","author":"EV Ilieva","year":"2007","journal-title":"Brain"},{"key":"pone.0292190.ref011","article-title":"XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy","author":"C Hetz","year":"2009","journal-title":"Genes Dev"},{"issue":"5","key":"pone.0292190.ref012","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s12192-018-0897-y","article-title":"Amyotrophic lateral sclerosis (ALS) and Alzheimer\u2019s disease (AD) are characterised by differential activation of ER stress pathways: focus on UPR target genes.","volume":"23","author":"L Montibeller","year":"2018","journal-title":"Cell Stress Chaperones"},{"issue":"3","key":"pone.0292190.ref013","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.nbd.2009.08.013","article-title":"Involvement of CHOP, an ER-stress apoptotic mediator, in both human sporadic ALS and ALS model mice","volume":"36","author":"Y Ito","year":"2009","journal-title":"Neurobiol Dis"},{"key":"pone.0292190.ref014","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jns.2018.01.035","article-title":"Expression analysis of protein homeostasis pathways in the peripheral blood mononuclear cells of sporadic amyotrophic lateral sclerosis patients","volume":"387","author":"A Vats","year":"2018","journal-title":"J Neurol Sci"},{"issue":"4","key":"pone.0292190.ref015","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00401-014-1336-5","article-title":"Aggregation-prone c9FTD\/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress.","volume":"128","author":"YJ Zhang","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"5","key":"pone.0292190.ref016","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1460-9568.2012.08008.x","article-title":"The unfolded protein response in models of human mutant G93A amyotrophic lateral sclerosis","volume":"35","author":"T Prell","year":"2012","journal-title":"Eur J Neurosci"},{"issue":"11","key":"pone.0292190.ref017","doi-asserted-by":"crossref","first-page":"e81170","DOI":"10.1371\/journal.pone.0081170","article-title":"ALS-associated TDP-43 induces endoplasmic reticulum stress, which drives cytoplasmic TDP-43 accumulation and stress granule formation.","volume":"8","author":"AK Walker","year":"2013","journal-title":"PLoS One."},{"issue":"11","key":"pone.0292190.ref018","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1101\/gad.1640108","article-title":"ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1","volume":"22","author":"H Nishitoh","year":"2008","journal-title":"Genes Dev"},{"issue":"15","key":"pone.0292190.ref019","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1073\/pnas.0509227103","article-title":"Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS model","volume":"103","author":"H Kikuchi","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"pone.0292190.ref020","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/hmg\/ddq546","article-title":"The unfolded protein response in familial amyotrophic lateral sclerosis","volume":"20","author":"L Wang","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"10","key":"pone.0292190.ref021","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1093\/hmg\/ddt658","article-title":"An enhanced integrated stress response ameliorates mutant SOD1-induced ALS","volume":"23","author":"L Wang","year":"2014","journal-title":"Hum Mol Genet"},{"key":"pone.0292190.ref022","doi-asserted-by":"crossref","first-page":"104702","DOI":"10.1016\/j.nbd.2019.104702","article-title":"Knockdown of GADD34 in neonatal mutant SOD1 mice ameliorates ALS.","volume":"136","author":"GD Ghadge","year":"2020","journal-title":"Neurobiol Dis"},{"key":"pone.0292190.ref023","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.nbd.2019.03.024","article-title":"The UPR-PERK pathway is not a promising therapeutic target for mutant SOD1-induced ALS","volume":"127","author":"Y Dzhashiashvili","year":"2019","journal-title":"Neurobiol Dis"},{"key":"pone.0292190.ref024","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/B978-0-12-385114-7.00002-7","article-title":"Assays for detecting the unfolded protein response","volume":"490","author":"K Cawley","year":"2011","journal-title":"Methods Enzymol"},{"issue":"4","key":"pone.0292190.ref025","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1471-4159.2007.05053.x","article-title":"Superoxide dismutase 1 mutants related to amyotrophic lateral sclerosis induce endoplasmic stress in neuro2a cells","volume":"104","author":"YK Oh","year":"2008","journal-title":"J Neurochem"},{"issue":"5","key":"pone.0292190.ref026","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nn.2297","article-title":"A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice","volume":"12","author":"S Saxena","year":"2009","journal-title":"Nat Neurosci"},{"issue":"2","key":"pone.0292190.ref027","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/ng.2853","article-title":"Therapeutic modulation of eIF2\u03b1 phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models","volume":"46","author":"HJ Kim","year":"2014","journal-title":"Nat Genet"},{"issue":"206","key":"pone.0292190.ref028","doi-asserted-by":"crossref","first-page":"206ra138","DOI":"10.1126\/scitranslmed.3006767","article-title":"Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice.","volume":"5","author":"JA Moreno","year":"2013","journal-title":"Sci Transl Med."},{"key":"pone.0292190.ref029","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.1201396","article-title":"Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis","volume":"332","author":"P Tsaytler","year":"2011","journal-title":"Science"},{"key":"pone.0292190.ref030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.nbd.2014.08.010","article-title":"Guanabenz, which enhances the unfolded protein response, ameliorates mutant SOD1 induced amyotrophic lateral sclerosis","volume":"71","author":"L Wang","year":"2014","journal-title":"Neurobiology of Disease"},{"key":"pone.0292190.ref031","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neuroscience.2014.03.047","article-title":"Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance, and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis","volume":"277","author":"HQ Jiang","year":"2014","journal-title":"Neuroscience"},{"issue":"8","key":"pone.0292190.ref032","doi-asserted-by":"crossref","first-page":"e0135570","DOI":"10.1371\/journal.pone.0135570","article-title":"Guanabenz Treatment Accelerates Disease in a Mutant SOD1 Mouse Model of ALS.","volume":"10","author":"FG Vieira","year":"2015","journal-title":"PLoS One."},{"key":"pone.0292190.ref033","first-page":"awab167","article-title":"The unfolded protein response in amyotrophic later sclerosis: results of a phase 2 trial","author":"ED Bella","year":"2021","journal-title":"Brain"},{"issue":"6231","key":"pone.0292190.ref034","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1126\/science.aaa4484","article-title":"Preventing proteostasis diseases by selective inhibition of a phosphatase regulatory subunit","volume":"348","author":"I Das","year":"2015","journal-title":"Science"},{"issue":"2","key":"pone.0292190.ref035","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/brain\/awy322","article-title":"sephin1, which prolongs the integrated stress response, is a promising therapeutic for multiple sclerosis","volume":"142","author":"Y Chen","year":"2019","journal-title":"Brain"},{"issue":"5","key":"pone.0292190.ref036","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1007\/s12035-020-01880-y","article-title":"sephin1 Reduces Prion Infection in Prion-Infected Cells and Animal Model","volume":"57","author":"S Thapa","year":"2020","journal-title":"Mol Neurobiol"},{"key":"pone.0292190.ref037","doi-asserted-by":"crossref","first-page":"e26109","DOI":"10.7554\/eLife.26109","article-title":"PPP1R15A-mediated dephosphorylation of eIF2\u03b1 is unaffected by Sephin1 or Guanabenz.","volume":"6","author":"A Crespillo-Casado","year":"2017","journal-title":"Elife"},{"issue":"20","key":"pone.0292190.ref038","doi-asserted-by":"crossref","first-page":"7766","DOI":"10.1074\/jbc.RA118.002325","article-title":"A sephin1-insensitive tripartite holophosphatase dephosphorylates translation initiation factor 2\u03b1","volume":"293","author":"A Crespillo-Casado","year":"2018","journal-title":"J Biol Chem"},{"issue":"7493","key":"pone.0292190.ref039","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/507423a","article-title":"Preclinical research: Make mouse studies work","volume":"507","author":"S. Perrin","year":"2014","journal-title":"Nature"},{"issue":"4","key":"pone.0292190.ref040","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/17482960701292837","article-title":"Guidelines for the preclinical in vivo evaluation of pharmacological active drugs for ALS\/MND: report on the 142nd ENMC international workshop.","volume":"8","author":"AC Ludolph","year":"2007","journal-title":"Amyotroph Lateral Scler."},{"issue":"1\u20132","key":"pone.0292190.ref041","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/17482960903545334","article-title":"Guidelines for preclinical animal research in ALS\/MND: A consensus meeting.","volume":"11","author":"AC Ludolph","year":"2010","journal-title":"Amyotroph Lateral Scler"},{"issue":"5166","key":"pone.0292190.ref042","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.8209258","article-title":"Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation","volume":"264","author":"ME Gurney","year":"1994","journal-title":"Science"},{"issue":"12","key":"pone.0292190.ref043","doi-asserted-by":"crossref","first-page":"e3276","DOI":"10.21769\/BioProtoc.3276","article-title":"A High-throughput qPCR-based Method to Genotype the SOD1G93A Mouse Model for Relative Copy Number.","volume":"9","author":"VR Tassinari","year":"2019","journal-title":"Bio Protoc."},{"key":"pone.0292190.ref044","volume-title":"Institute for Laboratory Animal Research (U.S.)-National (U.S.).","author":"Guide for the Care and Use of Laboratory Animals, eighth ed","year":"2010"},{"issue":"7","key":"pone.0292190.ref045","doi-asserted-by":"crossref","first-page":"RESEARCH0034","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"J Vandesompele","year":"2002","journal-title":"Genome Biol"},{"issue":"104","key":"pone.0292190.ref046","first-page":"53257","article-title":"A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1G93A Mouse Model of ALS.","volume":"6","author":"T Hatzipetros","year":"2015","journal-title":"J Vis Exp."},{"key":"pone.0292190.ref047","doi-asserted-by":"crossref","first-page":"100087","DOI":"10.1016\/j.crphar.2022.100087","article-title":"GSK2606414 attenuates PERK\/p-eIF2\u03b1\/ATF4\/CHOP axis and augments mitochondrial function to mitigate high glucose induced neurotoxicity in N2A cells.","volume":"3","author":"C Gundu","year":"2022","journal-title":"Curr Res Pharmacol Drug Discov."},{"key":"pone.0292190.ref048","doi-asserted-by":"crossref","first-page":"104581","DOI":"10.1016\/j.neuint.2019.104581","article-title":"Salubrinal attenuates nitric oxide mediated PERK:IRE1\u03b1: ATF-6 signaling and DNA damage in neuronal cells","volume":"131","author":"S Gupta","year":"2019","journal-title":"Neurochem Int"},{"issue":"7","key":"pone.0292190.ref049","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0006-2952(97)00631-X","article-title":"Ligand efficacy and potency at recombinant alpha2 adrenergic receptors: agonist-mediated [35S]GTPgammaS binding","volume":"55","author":"JR Jasper","year":"1998","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"pone.0292190.ref050","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00213-005-0220-3","article-title":"Effect of noradrenergic system on the anxiolytic-like effect of DOI (5-HT2A\/2C agonists) in the four-plate test.","volume":"183","author":"F Mass\u00e9","year":"2006","journal-title":"Psychopharmacology (Berl)."},{"issue":"17","key":"pone.0292190.ref051","doi-asserted-by":"crossref","first-page":"6088","DOI":"10.3390\/ijms21176088","article-title":"Sephin1 Protects Neurons against Excitotoxicity Independently of the Integrated Stress Response.","volume":"21","author":"A Ruiz","year":"2020","journal-title":"Int J Mol Sci."},{"issue":"1","key":"pone.0292190.ref052","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00000542-200201000-00026","article-title":"Effects of alpha(2)-adrenoceptor agonists on perinatal excitotoxic brain injury: comparison of clonidine and dexmedetomidine.","volume":"96","author":"V Laudenbach","year":"2002","journal-title":"Anesthesiology"},{"issue":"28","key":"pone.0292190.ref053","doi-asserted-by":"crossref","first-page":"12007","DOI":"10.1074\/jbc.A117.603393","article-title":"Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein-disulfide isomerase with superoxide dismutase 1","volume":"292","author":"JD Atkin","year":"2017","journal-title":"J Biol Chem"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0292190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T18:42:45Z","timestamp":1708022565000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0292190"}},"subtitle":[],"editor":[{"given":"Kent","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,2,15]]},"references-count":53,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0292190","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,15]]}}}